Welcome to OPT Congress:
Oligonucleotides & mRNA Therapeutics

OPT Congress is the premier conference for scientists and clinicians involved in discovering and developing oligonucleotides as therapeutics. NEW for 2024 we are delighted to expand our content and offer 2 conference programs dedicated to mRNA therapeutics to complement our established Oligo Discovery & Delivery and CMC & Regulatory programs. Now in its 9th year, this unique event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotides and mRNA therapeutics. In addition to 2 days of inspiring keynotes, interactive discussions and more than 95 scientific presentations, we deliver an in-depth, pre-conference dinner short course on the safety & toxicity of nucleic acids. We look forward to having you join us for this important scientific and networking event, that offers robust and customizable programming.